This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Universitè De Genève. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Sandra Margarete Kallert
Introduction
Sandra Margarete Kallert is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of virology, particularly in the development of vaccine vectors. Her work focuses on the engineering of arenaviruses, which are crucial for advancing immunotherapy and vaccine development.
Latest Patents
Kallert holds a patent for "Tri-segmented arenaviruses as vaccine vectors." This patent describes arenaviruses with rearrangements of their open reading frames (ORF) in their genomes. Specifically, it details a modified arenavirus genomic segment engineered to carry a viral ORF in a position different from its wild-type position. The patent also discusses trisegmented arenavirus particles that consist of one L segment and two S segments or two L segments and one S segment. These arenaviruses may be suitable for vaccines and treatments of diseases, as well as for use in immunotherapies. Kallert has 1 patent to her name.
Career Highlights
Kallert is affiliated with the Université de Genève, where she conducts her research. Her work has been instrumental in advancing the understanding of arenaviruses and their potential applications in medicine.
Collaborations
Throughout her career, Kallert has collaborated with notable researchers, including Daniel David Pinschewer and Doron Merkler. These collaborations have further enriched her research and contributed to the scientific community's knowledge of viral vectors.
Conclusion
Sandra Margarete Kallert's innovative work in the field of virology exemplifies the importance of research in developing effective vaccines and treatments. Her contributions continue to pave the way for advancements in immunotherapy and disease management.